Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

4 results

  • Characterizing the relationship between coronavirus disease 2019 (COVID-19) and central-line–associated bloodstream infection (CLABSI) and assessing the impact of a nursing-focused CLABSI reduction intervention during the COVID-19 pandemic

  • Michael A. Ben-Aderet, Meghan S. Madhusudhan, Pishoy Haroun, Matthew J.P. Almario, Ryan Raypon, Sharon Fawcett, Julie Johnson, Anita Girard, Todd Griner, Lorraine Sheffield, Jonathan D. Grein
  • Journal: Infection Control & Hospital Epidemiology / Volume 44 / Issue 7 / July 2023
  • Published online by Cambridge University Press: 31 August 2022, pp. 1108-1115
  • Print publication: July 2023
    • Article
      • You have access
      • Open access
    • PDF
    • HTML
    • Export citation
  • Objective:

    To examine the impact of SARS-CoV-2 infection on CLABSI rate and characterize the patients who developed a CLABSI. We also examined the impact of a CLABSI-reduction quality-improvement project in patients with and without COVID-19.

    Design:

    Retrospective cohort analysis.

    Setting:

    Academic 889-bed tertiary-care teaching hospital in urban Los Angeles.

    Patients or participants:

    Inpatients 18 years and older with CLABSI as defined by the National Healthcare Safety Network (NHSN).

    Intervention(s):

    CLABSI rate and patient characteristics were analyzed for 2 cohorts during the pandemic era (March 2020–August 2021): COVID-19 CLABSI patients and non–COVID-19 CLABSI patients, based on diagnosis of COVID-19 during admission. Secondary analyses were non–COVID-19 CLABSI rate versus a historical control period (2019), ICU CLABSI rate in COVID-19 versus non–COVID-19 patients, and CLABSI rates before and after a quality- improvement initiative.

    Results:

    The rate of COVID-19 CLABSI was significantly higher than non–COVID-19 CLABSI. We did not detect a difference between the non–COVID-19 CLABSI rate and the historical control. COVID-19 CLABSIs occurred predominantly in the ICU, and the ICU COVID-19 CLABSI rate was significantly higher than the ICU non–COVID-19 CLABSI rate. A hospital-wide quality-improvement initiative reduced the rate of non–COVID-19 CLABSI but not COVID-19 CLABSI.

    Conclusions:

    Patients hospitalized for COVID-19 have a significantly higher CLABSI rate, particularly in the ICU setting. Reasons for this increase are likely multifactorial, including both patient-specific and process-related issues. Focused quality-improvement efforts were effective in reducing CLABSI rates in non–COVID-19 patients but were less effective in COVID-19 patients.